Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins

Journal of Proteome Research

Volumn 6, Issue 10, 2007, Pages 3952-3961

  Nilsson, Anna ^a   Sköld, Karl ^a   Sjögren, Benita ^b   Svensson, Marcus ^a   Pierson, Johan ^a   Zhang, Xiaoqun ^b   Caprioli, Richard M ^c   Buijs, Jos ^d   Persson, Björn ^d   Svenningsson, Per ^b   Andrén, Per E ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BIACORE AB   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

6 OHDA; Mass spectrometry; Parkinson's disease; Protein interactions; Proteomics; Striatum

Indexed keywords

14 3 3 DELTA PYRUVATE KINASE; 14 3 3 ZETA PYRUVATE KINASE; ALPHA ENOLASE; FK 506 BINDING PROTEIN; HEAT SHOCK PROTEIN 70; IMMUNOPHILIN; MESSENGER RNA; OXIDOPAMINE; PYRUVATE KINASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GEL ELECTROPHORESIS; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, LIQUID; CORPUS STRIATUM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTATHIONE TRANSFERASE; IN SITU HYBRIDIZATION; MALE; MICE; MOLECULAR SEQUENCE DATA; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURFACE PLASMON RESONANCE; TACROLIMUS BINDING PROTEIN 1A;

ANIMALIA; RATTUS;

EID: 35648966146     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070189e     Document Type: Article

References (61)

1. Hornykiewicz, O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br. Med. Bull. 1973, 29 (2), 172-178.
2. Schapira, A. H. Disease modification in Parkinson's disease. Lancet Neurol. 2004, 3 (6), 362-368.
3. Samii, A.; Nutt, J. G.; Ransom, P. B. R., Parkinson's disease. Lancet 2004, 363 (9423), 1783-1793.
4. Polymeropoulos, M. H.; Lavedan, C.; Leroy, E.; Ide, S. E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E. S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W. G.; Lazzarini, A. M.; Duvoisin, R. C.; Di, Iorio, G.; Golbe, L. I.; Nussbaum, R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276 (5321), 2045-2047.
5. Leroy, E.; Boyer, R.; Auburger, G.; Leube, B.; Ulm, G.; Mezey, E.; Harta, G.; Brownstein, M. J.; Jonnalagada, S.; Chernova, T.; Dehejia, A.; Lavedan, C.; Gasser, T.; Steinbach, P. J.; Wilkinson, K. D.; Polymeropoulos, M. H. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395 (6701), 451-452.
6. Kish, S. J.; Shannak, K.; Hornykiewicz, O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 1988, 318 (14), 876-880.
7. Gold, B. G.; Nutt, J. G. Neuroimmunophilin ligands in the treatment of Parkinson's disease. Curr. Opin. Pharmacol. 2002, 2 (1), 82-86.
8. Snyder, S. H.; Lai, M. M.; Burnett, P. E. Immunophilins in the nervous system. Neuron 1998, 21 (2), 283-294.
9. Liu, J.; Farmer, J. Jesse, D.; Lane, W. S.; Friedman, J.; Weissman, I.; Schreiber, S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66 (4), 807-815.
10. Costantini, L. C.; Chaturvedi, P.; Armistead, D. M.; McCaffrey, P. G.; Deacon, T. W.; Isacson, O. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease. Neurobiol. Dis. 1998, 5 (2), 97-106.
11. Gold, B.; Katoh, K.; Storm-Dickerson, T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 1995, 15 (11), 7509-7516.
12. Madsen, J. R.; MacDonald, P.; Irwin, N.; Goldberg, D. E.; Yao, G.-L.; Meiri, K. F.; Rimm, I. J.; Stieg, P. E.; Benowitz, L. I., Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 1998, 154 (2), 673-683.
13. Bavetta, S.; Hamlyn, P. J.; Burnstock, G.; Lieberman, A. R.; Anderson, P. N. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 1999, 158 (2), 382-393.
14. Gold, B. G. FK506 and the role of immunophilins in nerve regeneration. Mol. Neurobiol. 1997, 15 (3), 285-306.
15. Aghdasi, B.; Ye, K.; Resnick, A.; Huang, A.; Ha, H. C.; Guo, X.; Dawson, T. M.; Dawson, V. L.; Snyder, S. H. FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (5), 2425-2430.
16. Hemenway, C. S.; Heitman, J. Calcineurin. Structure, function, and inhibition. Cell Biochem. Biophys. 1999, 30 (1), 115-151.
17. Marti, M. J.; James, C. J.; Oo, T. F.; Kelly, W. J.; Burke, R. E. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 1997, 17 (6), 2030-2039.
18. Choi, W. S.; Yoon, S. Y.; Oh, T. H.; Choi, E. J.; O'Malley, K. L.; Oh, Y. J. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 1999, 57 (1), 86-94.
19. Mikol, D. D.; Feldman, E. L. Neurophilins and the nervous system. Muscle Nerve 1999, 22 (10), 1337-1340.
20. Zhukov, A.; Schurenberg, M.; Jansson, O.; Areskoug, D.; Buijs, J. Integration of surface plasmon resonance with mass spectrometry: automated ligand fishing and sample preparation for MALDI MS using a Biacore 3000 biosensor. J. Biomol. Tech. 2004, 15 (2), 112-119.
21. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates, 4th ed.; Academic Press: San Diego, CA, 1998.
22. Ungerstedt, U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 1971, 367, 69-93.
23. Svenningsson, P.; Gunne, L.; Andren, P. E., L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience 2000, 99 (3), 457-468.
24. Heukeshoven, J.; Dernik, R. Simplified method for silverstaining of proteins in Polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985, 6 (3), 103-112.
25. Neuhoff, V.; Arnold, N.; Taub, D.; Erhardt, W. Improved staining of proteins in Polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9 (6), 255-262.
26. Hillenkamp, M. K. a. F., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60 (20), 2299-2301.
27. Svenningsson, P.; Le Moine, C.; Kull, B.; Sunahara, R.; Bloch, B.; Fredholm, B. B. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 1997, 80 (4), 1171-1185.
28. Towbin, H.; Staehlin, T.; J. G. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1999, 76 4350-4354.
29. Pierson, J.; Svenningsson, P.; Caprioli, R. M.; Andren, P. E. Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats. J. Proteome Res. 2005, 4 (2), 223-226.
30. Pierson, J.; Norris, J. L.; Aerni, H. R.; Svenningsson, P.; Caprioli, R. M.; Andren, P. E. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J. Proteome Res. 2004, 3 (2), 289-295.
31. Chaurand, P.; Caprioli, R. M. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002, 23 (18), 3125-3135.
32. Carman, L. S.; Gage, F. H.; Shults, C. W. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 1991, 553 (2), 275-283.
33. Canfield, D. R.; Spealman, R. D.; Kaufman, M. J.; Madras, B. K. Autoradiographic localization of cocaine binding sites by [3H]-CFT ([3H]WIN 35,428) in the monkey brain. Synapse 1990, 6 (2), 189-195.
34. Soucy, J. P.; Mrini, A.; Lafaille, F.; Doucet, G.; Descarries, L. Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain. Synapse 1997, 25 (2), 163-175.
35. Cameron, A. M.; Steiner, J. P.; Roskams, A. J.; Ali, S. M.; Ronnettt, G. V.; Snyder, S. H. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 1995, 83 (3), 463-472.
36. Avramut, M.; Achim, C. L. Immunophilins and their ligands: insights into survival and growth of human neurons. Physiol. Behav. 2002, 77 (4-5), 463-468.
37. Skene, J. H.; Jacobson, R. D.; Snipes, G. J.; McGuire, C. B.; Norden, J. J.; Freeman, J. A. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science 1986, 233 (4765), 783-786.
38. Lyons, W.; Steiner, J.; Snyder, S.; Dawson, T. Neuronal regeneration enhances the expression of the immunophilin FKBP- 12. J. Neurosci. 1995, 15 (4), 2985-2994.
39. Seth, K.; Agrawal, A. K.; Aziz, M. H.; Ahmad, A.; Shukla, Y.; Mathur, N.; Seth, P. K. Induced expression of early response genes/ oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease. Neurosci. Lett. 2002, 330 (1), 89-93.
40. Shen, Y.; Mani, S.; Meiri, K. F. Failure to express GAP-43 leads to disruption of a multipotent precursor and inhibits astrocyte differentiation. Mol. Cell. Neurosci. 2004, 26 (3), 390-405.
41. Glinka, Y.; Gassen, M.; Youdim, M. B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 1997, 50, 55-66.
42. Merad-Boudia, M.; Nicole, A.; Santiard-Baron, D.; Saille, C.; Ceballos-Picot, I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 1998, 56 (5), 645-655.
43. Roderick, H. L.; Bootman, M. D. Redoxing Calcium from the ER. Cell 2005, 120 (1), 4-5.
44. Gotz, M. E.; Kunig, G.; Riederer, P.; Youdim, M. B., Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 1994, 63 (1), 37-122.
45. Fahn, S.; Cohen, G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 1992, 32 (6), 804-812.
46. Poon, H. F.; Shepherd, H. M.; Reed, T. T.; Calabrese, V.; Stella, A. M.; Pennisi, G.; Cai, J.; Pierce, W. M.; Klein, J. B.; Butterfield, D. A. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 2006, 27 (7), 1020-1034.
47. Fu, H.; Subramanian, R. R.; Masters, S. C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617-647.
48. Mori, H.; Inoue, M.; Yano, M.; Wakabayashi, H.; Kido, H., 14-3-3tau associates with a translational control factor FKBP12-rapamycin-associated protein in T-cells after stimulation by pervanadate. FEBS Lett. 2000, 467 (1), 61-64.
49. Beguin, P.; Mahalakshmi, R. N.; Nagashima, K.; Cher, D. H.; Takahashi, A.; Yamada, Y.; Seino, Y.; Hunziker, W. 14-3-3 and calmodulin control subcellular distribution of Kir/Gem and its regulation of cell shape and calcium channel activity. J. Cell Sci. 2005, 118, (Pt 9), 1923-1934.
50. Georgopoulos, C.; Welch, W. J. Role of the major heat shock proteins as molecular chaperones. Annu. Rev. Cell Biol. 1993, 9, 601-634.
51. McNaught, K. S.; Shashidharan, P.; Perl, D. P.; Jenner, P.; Olanow, C. W., Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 2002, 16 (11), 2136-2148.
52. Takai, A.; Mieskes, G., Inhibitory effect of okadaic acid on the p-nitrophenyl phosphate phosphatase activity of protein phosphatases. Biochem. J. 1991, 275 (Pt 1), 233-239.
53. Hutchinson, K. A.; Brott, B. K.; De Leon, J. H.; Perdew, G. H.; Jove, R.; Pratt, W. B. Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free system. J. Biol. Chem. 1992, 267 (5), 2902-2908.
54. Massol, N.; Lebeau, M. C.; Renoir, J. M.; Faber, L. E.; Baulieu, E. E. Rabbit FKBP59-heat shock protein binding immunophillin (HBI) is a calmodulin binding protein. Biochem. Biophys. Res. Commun. 1992, 187 (3), 1330-1335.
55. Ning, Y. M.; Sanchez, E. R. Evidence for a functional interaction between calmodulin and the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 1995, 208 (1), 48-54.
56. Someren, J. S.; Faber, L. E.; Klein, J. D.; Tumlin, J. A. Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms. Biochem. Biophys. Res. Commun. 1999, 260 (3), 619-625.
57. Lovell, M. A.; Xiong, S.; Markesbery, W. R.; Lynn, B. C. Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem. Res. 2005, 30 (1), 113-122.
58. Svensson, M.; Skold, K.; Nilsson, A.; Faith, M.; Nydahl, K.; Svenningsson, P.; Andren, P. E. Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal. Chem. 2007, 79 (1), 15-16, 18-21.
59. Svensson, M.; Skold, K.; Nilsson, A.; Faith, M.; Svenningsson, P.; Andren, P. E. Neuropeptidomics: expanding proteomics downwards. Biochem. Soc. Trans. 2007, 35 (Pt. 3), 588-593.
60. Svensson, M.; Skold, K.; Svenningsson, P.; Andren, P. E. Peptidomics-based discovery of novel neuropeptides. J. Proteome Res. 2003, 2 (2), 213-219.
61. Skold, K.; Svensson, M.; Kaplan, A.; Bjorkesten, L.; Astrom, J.; Andren, P. E. A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics 2002, 2 (4), 447-454.